|
Risk of cancer-specific death for patients diagnosed with neuroendocrine tumors: A population-based analysis. |
|
|
Honoraria - Ipsen; Novartis |
Travel, Accommodations, Expenses - Baxter |
|
|
Honoraria - Ipsen; Novartis |
Travel, Accommodations, Expenses - Baxter |
|
|
Employment - AstraZeneca (I); Sanofi (I) |
Honoraria - Ipsen; Novartis |
Consulting or Advisory Role - Isotopen Technologien |
Research Funding - EMD Serono (Inst); Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |